Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Spot® Ex Endoscopic Tattoo Krijgt CE Keurmerk - Wordt Gelanceerd in Europa
  • USA - Italiano
  • USA - Français
  • USA - Deutsch
  • USA - español

Spot® Ex Endoscopic Tattoo logo

News provided by

GI Supply, Inc.

May 07, 2018, 01:20 ET

Share this article

Share toX

Share this article

Share toX

Naar aanleiding van het persbericht Spot® Ex Endoscopic Tattoo Krijgt CE Keurmerk - Wordt Gelanceerd in Europa, gepubliceerd op 07-mei-2018 door GI Supply, Inc. via PR Newswire, hebben wij van het bedrijf informatie ontvangen dat het onderschrift bij de foto zou moeten luiden: "Spot Ex® is the only endoscopic tattoo to have a long-term clinical surveillance indication that empowers gastroenterologists to implement the new ESGE guidelines." Dit vervangt de originele tekst. Het complete en gecorrigeerde persbericht volgt hier:

Spot® Ex Endoscopic Tattoo Krijgt CE Keurmerk - Wordt Gelanceerd in Europa

Helpt Gastro-enterologen en Chirurgen bij Invoering Nieuwe Richtlijnen van de European Society for Gastrointestinal Endoscopy  (ESGE)

LONDEN, 7 mei 2018 /PRNewswire/ -- GI Supply, Inc. heeft vandaag bekendgemaakt dat zijn Spot® Ex Endoscopic Tattoo het CE Keurmerk heeft ontvangen en vanaf nu beschikbaar is in Europa. Spot Ex® wordt gebruikt voor het endoscopisch markeren van kankerweefsel, verdachte laesies en poliepen om toekomstige identificatie te vergemakkelijken bij follow-up colonoscopische procedures of na een operatie. Het is de enige endoscopische tatoeage die over een langere termijn wordt voorgeschreven voor klinische surveillance en waarmee gastroenterologen in staat zijn om de nieuwe ESGE richtlijnen uit te voeren. 

Spot Ex® is the only endoscopic tattoo to have a long-term clinical surveillance indication that empowers gastroenterologists to implement the new ESGE guidelines.
Spot Ex® is the only endoscopic tattoo to have a long-term clinical surveillance indication that empowers gastroenterologists to implement the new ESGE guidelines.

"Vorderingen in screening en therapie helpen het aantal sterfgevallen door darmkanker in Europa te verminderen. Polypectomie en EMR zijn tegenwoordig normale vaardigheden voor gastroenterologen, en geven patiënten de mogelijkheid om kanker te laten genezen zonder de traditionele operatie," aldus Professor Cesare Hassan, Hoofd van de eenheid Endoscopie bij Nuovo Regina Margherita Hospital in Rome. "De nieuwe ESGE richtlijnen, geformuleerd door de beste experts wereldwijd, bevelen follow‐up aan over langere termijn van patiënten die deze procedures hadden gevolgd, om recidieven op te sporen en te behandelen, zodat het risico op intervaltumoren wordt verkleind."  Professor Hassan voegde hieraan toe: "Ik ben zeer verheugd dat wij beschikken over Spot Ex, omdat het de enige tatoeage is die op medische indicatie gebruikt wordt voor langdurige klinische surveillance."

De nieuwe ESGE richtlijnen bevelen tatoeëring aan van all laesies die bij toekomstige colonoscopie en operaties follow-up krijgen (Ferlitsch 2017).  Spot Ex® is de enige endoscopisch tatoeage die op medische indicatie wordt voorgeschreven bij lange-termijn klinische surveillance. 

De nieuwe Spot Ex samenstelling is veel donkerder getint dan het huidige Spot product, waardoor de tatoeage makkelijker vindbaar is en endoscopisten en chirurgen hun tijd en productiviteit beter kunnen managen. Twee nieuwe klinische studies zijn uitgevoerd om 100% zichtbaarheid van Spot te verifiëren bij klinische follow-up procedures tot 11 jaar na dato. (Cano 2017 en Jackson 2017). 

"Onze missie bij GI Supply is om meer maag-darmspecialisten te helpen met het veilig en efficiënt uitvoeren van meer geavanceerde endoscopische procedures, en Spot Ex is een geweldige volgende stap in het vervullen van deze behoeften," aldus Luke Johnson, CEO van GI Supply. "Wij zijn verheugd dat we de beschikbaarheid van Spot Ex op de Europese markt kunnen uitbreiden en clinici kunnen voorzien van een vervolgstap in de strijd tegen darmkanker." 

Over GI Supply:  GI Supply, Inc. is een particuliere onderneming gevestigd in Camp Hill, Philadephia, en werd bijna 30 jaar geleden opgericht door Dr. Frank Jackson, gastroenteroloog en ondernemer, met als doel het helpen aangaan van veel klinische uitdagingen waar hij dagelijks mee te maken had. Tegenwoordig worden GI Supply producten over de hele wereld gebruikt door gastroenterologen en colorectale chirurgen in meer dan 50 landen.

Meer over Spot Ex op http://www.spotextattoo.eu

Vind een Europese Distributeur van Spot Ex

CONTACTINFORMATIE

Media

Contact: Caroline Abrego, Europees Marketing Manager

Tel.: +44 7831482380

E-mail: [email protected]

Foto - https://mma.prnewswire.com/media/629087/GI_Supply_Spot_Ex.jpg

Logo - https://mma.prnewswire.com/media/629086/Spot_Ex_Logo.jpg

Related Links

http://www.gi-supply.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.